Twitter

Link your Twitter Account to Market Wire News


When you linking your Twitter Account Market Wire News Trending Stocks news and your Portfolio Stocks News will automatically tweet from your Twitter account.


Be alerted of any news about your stocks and see what other stocks are trending.



home / news releases / LGND - Ligand Pharmaceuticals And The OmniAb Platform


LGND - Ligand Pharmaceuticals And The OmniAb Platform

Market Assessment

In the last 12 months, the price of Ligand (LGND) stock has depreciated from a high of ~$252 on September 6th, 2018, to today’s price of ~$88. As a small market cap ($1.7B) creating and/or acquiring technologies to develop innovative therapeutics, LGND has a unique business model focused on licensing out/partnering with other biopharmas to clinically develop innovative drug candidates. Ligand describes its business model as creating "value for stockholders by providing a diversified portfolio of biotech and pharmaceutical product revenue streams that are supported by an efficient and low corporate

Read more ...

Stock Information

Company Name: Ligand Pharmaceuticals Incorporated
Stock Symbol: LGND
Market: NASDAQ
Website: ligand.com

Menu

LGND LGND Quote LGND Short LGND News LGND Articles LGND Message Board
Get LGND Alerts

News, Short Squeeze, Breakout and More Instantly...